Earnings Feed
Start Free
Home/Filings/4/0001209191-17-051986
4//SEC Filing

Versant Venture Capital V (Canada), LP 4

Accession 0001209191-17-051986

CIK 0001674416other
View on SEC.govCompany Profile

Filed

Sep 6, 8:00 PM ET

Accepted

Sep 7, 9:35 PM ET

Size

40.9 KB

Accession

0001209191-17-051986

Insider Transaction Report

Form 4
Period: 2017-09-05
CRISPR Therapeutics AGCRSP
Versant Venture Capital V, L.P.
10% Owner
Transactions
  • Other

    Common Stock

    2017-09-05−17,283→ 0 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−1,240→ 0 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−8,110→ 16,224 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−814,599→ 1,629,204 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−61,993→ 123,994 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−1,368,013→ 2,736,032 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−23,899→ 47,801 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−292,529→ 0 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−26,491→ 52,987 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05+292,529→ 292,529 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05+17,283→ 17,283 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05+1,240→ 1,240 total(indirect: see footnote)
Versant Affiliates Fund V, L.P.
10% Owner
Transactions
  • Other

    Common Stock

    2017-09-05−8,110→ 16,224 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05+17,283→ 17,283 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−17,283→ 0 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−1,240→ 0 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−1,368,013→ 2,736,032 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−814,599→ 1,629,204 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−23,899→ 47,801 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−61,993→ 123,994 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−26,491→ 52,987 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05+292,529→ 292,529 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−292,529→ 0 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05+1,240→ 1,240 total(indirect: see footnote)
Versant Ophthalmic Affiliates I, L.P.
10% Owner
Transactions
  • Other

    Common Stock

    2017-09-05−61,993→ 123,994 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05+17,283→ 17,283 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−17,283→ 0 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−8,110→ 16,224 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−26,491→ 52,987 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−292,529→ 0 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−814,599→ 1,629,204 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−23,899→ 47,801 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−1,240→ 0 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−1,368,013→ 2,736,032 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05+292,529→ 292,529 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05+1,240→ 1,240 total(indirect: see footnote)
Versant Venture Capital V (Canada), LP
10% Owner
Transactions
  • Other

    Common Stock

    2017-09-05−1,368,013→ 2,736,032 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−23,899→ 47,801 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05+292,529→ 292,529 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−814,599→ 1,629,204 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−61,993→ 123,994 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−17,283→ 0 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−8,110→ 16,224 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−26,491→ 52,987 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−292,529→ 0 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05+1,240→ 1,240 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05+17,283→ 17,283 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−1,240→ 0 total(indirect: see footnote)
Versant Ventures IV, LLC
10% Owner
Transactions
  • Other

    Common Stock

    2017-09-05−814,599→ 1,629,204 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−17,283→ 0 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−26,491→ 52,987 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05+17,283→ 17,283 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05+292,529→ 292,529 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−61,993→ 123,994 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−1,240→ 0 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−8,110→ 16,224 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05+1,240→ 1,240 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−1,368,013→ 2,736,032 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−23,899→ 47,801 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−292,529→ 0 total(indirect: see footnote)
Versant Ventures V, LLC
10% Owner
Transactions
  • Other

    Common Stock

    2017-09-05−61,993→ 123,994 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−1,368,013→ 2,736,032 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−814,599→ 1,629,204 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−292,529→ 0 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05+17,283→ 17,283 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−17,283→ 0 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05+1,240→ 1,240 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−8,110→ 16,224 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−23,899→ 47,801 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−26,491→ 52,987 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05+292,529→ 292,529 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−1,240→ 0 total(indirect: see footnote)
Versant Ventures V (Canada), L.P.
10% Owner
Transactions
  • Other

    Common Stock

    2017-09-05−8,110→ 16,224 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05+292,529→ 292,529 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05+17,283→ 17,283 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−17,283→ 0 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−1,368,013→ 2,736,032 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05+1,240→ 1,240 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−26,491→ 52,987 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−292,529→ 0 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−23,899→ 47,801 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−814,599→ 1,629,204 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−61,993→ 123,994 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−1,240→ 0 total(indirect: see footnote)
Versant Venture Capital IV, L.P.
10% Owner
Transactions
  • Other

    Common Stock

    2017-09-05−23,899→ 47,801 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−26,491→ 52,987 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05+292,529→ 292,529 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−17,283→ 0 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−8,110→ 16,224 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−814,599→ 1,629,204 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−61,993→ 123,994 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−1,240→ 0 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−1,368,013→ 2,736,032 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−292,529→ 0 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05+17,283→ 17,283 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05+1,240→ 1,240 total(indirect: see footnote)
Versant Side Fund IV, L.P.
10% Owner
Transactions
  • Other

    Common Stock

    2017-09-05−17,283→ 0 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05+17,283→ 17,283 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05+1,240→ 1,240 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−1,240→ 0 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−8,110→ 16,224 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−814,599→ 1,629,204 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−23,899→ 47,801 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05+292,529→ 292,529 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−292,529→ 0 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−1,368,013→ 2,736,032 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−61,993→ 123,994 total(indirect: see footnote)
  • Other

    Common Stock

    2017-09-05−26,491→ 52,987 total(indirect: see footnote)
Footnotes (21)
  • [F1]Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant Venture Capital IV, L.P. ("VVC IV") without consideration to its partners.
  • [F10]These securities are held of record by VVC CAN. Versant Ventures V GP-GP (Canada), Inc. ("VV V CAN GP") is the sole general partner of Versant Ventures V (Canada), L.P. ("VV V CAN") and VV V CAN is the sole general partner of VVC CAN. VV V CAN GP and VV V CAN may be deemed to have voting and investment power over the securities held by VVC CAN and as a result may be deemed to have beneficial ownership over such securities, however, each disclaim beneficial ownership of the securities held by VVC CAN, except to the extent of their respective pecuniary interests therein.
  • [F11]Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant Ophthalmic Affiliates Fund I, L.P. ("VOA") without consideration to its partners.
  • [F12]These securities are held of record by VOA. VV V is the sole general partner of VOA and may be deemed to have voting and investment power over the securities held by VOA and as a result may be deemed to have beneficial ownership over such securities, however, VV V disclaims beneficial ownership of the securities held by VOA, except to the extent of its pecuniary interest therein.
  • [F13]Represents a change in the form of ownership of VV IV by virtue of the receipt of shares in the pro-rata in-kind distribution of Common Stock of the Issuer for no consideration by VVC IV and VSF IV.
  • [F14]The shares are held VV IV.
  • [F15]Represents a pro-rata in-kind distribution of Common Stock of the Issuer by VV IV without consideration to its members.
  • [F16]Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of Common Stock of the Issuer for no consideration by VVC V, VAF V and VOA.
  • [F17]The shares are held VV V.
  • [F18]. Represents a pro-rata in-kind distribution of Common Stock of the Issuer by VV V without consideration to its members.
  • [F19]Represents a change in the form of ownership of VV V CAN by virtue of the receipt of shares in the pro-rata in-kind distribution of Common Stock of the Issuer for no consideration by VVC CAN.
  • [F2]These securities are held of record by VVC IV. Versant Ventures IV, LLC ("VV IV") is the sole general partner of VVC IV and may be deemed to have voting and investment power over the securities held by VVC IV and as a result may be deemed to have beneficial ownership over such securities, however, VV IV disclaims beneficial ownership of the securities held by VVC IV, except to the extent of its pecuniary interest therein.
  • [F20]The shares are held VV V CAN.
  • [F21]Represents a pro-rata in-kind distribution of Common Stock of the Issuer by VV V CAN without consideration to its partners.
  • [F3]Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant Side Fund IV, L.P. ("VSF IV") without consideration to its partners.
  • [F4]These securities are held of record by VSF IV. VV IV is the sole general partner of VSF IV and may be deemed to have voting and investment power over the securities held by VSF IV and as a result may be deemed to have beneficial ownership over such securities, however, VV IV disclaims beneficial ownership of the securities held by VSF IV, except to the extent of its pecuniary interest therein.
  • [F5]Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant Venture Capital V, L.P. ("VVC V") without consideration to its partners.
  • [F6]These securities are held of record by VVC V. Versant Ventures V, LLC ("VV V") is the sole general partner of VVC V and may be deemed to have voting and investment power over the securities held by VVC V and as a result may be deemed to have beneficial ownership over such securities, however, VV V disclaims beneficial ownership of the securities held by VVC V, except to the extent of its pecuniary interest therein.
  • [F7]Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant Affiliates Fund V, L.P. ("VAF V") without consideration to its partners.
  • [F8]These securities are held of record by VAF V. VV V is the sole general partner of VAF V and may be deemed to have voting and investment power over the securities held by VAF V and as a result may be deemed to have beneficial ownership over such securities, however, VV V disclaims beneficial ownership of the securities held by VAF V, except to the extent of its pecuniary interest therein.
  • [F9]Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant Venture Capital V (Canada) LP ("VVC CAN") without consideration to its partners.

Documents

1 file

Issuer

CRISPR Therapeutics AG

CIK 0001674416

→
Entity typeother
IncorporatedOntario, Canada

Related Parties

1
  • filerCIK 0001612235

Filing Metadata

Form type
4
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 9:35 PM ET
Size
40.9 KB
View on SEC.gov